Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-of-function mutation
Abstract Background We aimed to report the clinical characteristics, immunological features, and treatment of one patient with a de novo STAT3 gain-of-function mutation identified by next generation sequencing. We investigated the efficacy of tocilizumab therapy in immune dysregulation diseases caus...
Main Authors: | Wenjie Wang, Luyao Liu, Xiaoying Hui, Ying Wang, Wenjing Ying, Qinhua Zhou, Jia Hou, Mi Yang, Bijun Sun, Jinqiao Sun, Xiaochuan Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | BMC Immunology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12865-021-00411-1 |
Similar Items
-
Tocilizumab inhibits neuronal cell apoptosis and activates STAT3 in cerebral infarction rat model
by: Shaojun Wang, et al.
Published: (2016-01-01) -
The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations
by: Li Lin, et al.
Published: (2020-07-01) -
A new bioassay for measuring the strength of IL-6/STAT3 signal inhibition by tocilizumab in patients with rheumatoid arthritis
by: Shuntaro Saito, et al.
Published: (2017-10-01) -
STAT1 Gain-of-Function Mutations Cause High Total STAT1 Levels With Normal Dephosphorylation
by: Ofer Zimmerman, et al.
Published: (2019-07-01) -
RAPID EFFECT OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS
by: E Yu Panasyuk, et al.
Published: (2011-08-01)